AI-native compliance automation for regulated medical device teams
Ketryx builds an overlay platform that injects AI agents into the product development workflows of regulated manufacturers—automating compliance documentation, traceability, and release gates without replacing existing tools. The stack (TypeScript, React, PostgreSQL, Kubernetes on AWS) is mid-scale and modernizing (adopting Next.js, GraphQL, Prisma), while active projects reveal a company scaling both platform depth (AI agents, QMS deployment automation) and go-to-market surface (partner program launch, co-selling enablement). Leadership gaps in legal (building function from scratch) and the presence of channel and strategic partnership roles suggest a partner-led GTM strategy alongside direct sales.
Notable leadership hires: Channel Partnerships Director, QA/RA Lead, Strategic Partnerships Director
Ketryx is a compliance automation platform for medical device manufacturers and other regulated product teams. The company operates as an AI-native overlay that integrates with existing development tools—JIRA, document management systems, ERP platforms—to automate documentation generation, enforce traceability requirements, and accelerate time-to-market for FDA and ISO 13485 regulated releases. Founded in 2021 and based in Cambridge, MA, Ketryx serves a high-value, low-velocity buyer base (mid-market and enterprise device OEMs). The product is structured around three operational vectors: compliance automation (reducing manual QMS work), deployment and setup services for customer quality systems, and a nascent partner ecosystem for distribution and co-selling.
TypeScript, React, PostgreSQL, Kubernetes, and AWS infrastructure. The platform is adopting Next.js, GraphQL, Apollo, Prisma, and AWS RDS for modernization. Testing is covered by Playwright, Cucumber, and Jest.
Cambridge, MA. The company hires in the United States and Austria.
Other companies in the same industry, closest in size